Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
Raiola
P
P
Institute of Internal Medicine and Nephrology, School of Medicine, Second University of Naples, Italy.
Manzo
M
M
Saggese
A
A
Tomasino
G
G
Cicchella
T
T
Rambaldi
M
M
Pisano
M
M
Lizza
B
B
Perna
A F
AF
D000328:Adult; D000595:Amino Acid Sequence; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D016305:Thymopentin / Q000737:chemistry / Q000627:therapeutic use*
D011994:Recombinant Proteins; D004921:Erythropoietin; D016305:Thymopentin